Response to comments to the editor on "Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers".

Ali, Ayad M; Tofiq, Ahmed M; Rostam, Hassan M; Ali, Kameran M; Tawfeeq, Hassan M

Response to comments to the editor on "Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers".

Ali, Ayad M; Tofiq, Ahmed M; Rostam, Hassan M; Ali, Kameran M; Tawfeeq, Hassan M.

Ali AM; Department of Chemistry, University of Garmian, Kalar, Kurdistan Region, Iraq.
Tofiq AM; Department of Biology, College of Education, University of Garmian, Kalar, Kurdistan Region, Iraq.
Rostam HM; Centauri Therapeutics LTD, Cheshire, England, United Kingdom.
Ali KM; Medical Lab Technology Department, Kalar Technical College, Sulaimani Polytechnic University, Kalar, Kurdistan Region, Iraq.
Tawfeeq HM; Medical Lab Technology Department, Kalar Technical College, Sulaimani Polytechnic University, Kalar, Kurdistan Region, Iraq.

J Med Virol ; 95(5): e28820, 2023 05.

Artículo en Inglés | MEDLINE | ID: covidwho-20232106

Asunto(s)

COVID-19; SARS-CoV-2; Humanos; COVID-19/prevención & control; Gravedad del Paciente

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Estudio pronóstico Tópicos: Vacunas / Variantes Límite: Humanos Idioma: Inglés Revista: J Med Virol Año: 2023 Tipo del documento: Artículo País de afiliación: Jmv.28820

Similares

MEDLINE

LILACS

LIS

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google